Article information
Abstract
In the context of solid organ transplantation, screening of potential organ donors is crucial, and should be performed with great rigor to minimize the risk of transmission of certain infectious processes. This review aims to update understanding of the possible pathologies involved, as well as of emerging infections that, as a result of globalization, are gaining increasing prominence on a daily basis.
Keywords:
Infection
Donor-to-host transmission
Transplantation
Resumen
En el contexto del trasplante de órgano sólido, la evaluación previa del donante representa una actuación muy importante que se debe efectuar con sumo rigor, para minimizar al máximo el riesgo de transmisión de ciertos procesos infecciosos. Esta revisión pretende actualizar los conocimientos sobre las posibles patologías implicadas así como el conjunto de infecciones emergentes que, como consecuencia de la globalización, adquieren día a día un creciente protagonismo.
Palabras clave:
Infección
Transmisión donante-receptor
Trasplante
Full text is only aviable in PDF
References
[1.]
R.K. Avery, P. Ljungman.
Prophylactic measures in the solid-organ recipient before transplantation.
Clin Infect Dis, 33 (2001), pp. S15-S21
[2.]
A. Schaffner.
Pretransplant evaluation for infections in donors and recipients of solid organs.
Clin Infect Dis, 33 (2001), pp. S9-S14
[3.]
Criterios de selección del donante de órganos respecto a la transmisión de infecciones. Documento de consenso ONT-GESITRA. 2nd ed. 2004. Accessed at: http://www.seimc.org/grupos/gesitra/index.asp?apV=produccion≈V1=DyC≈nv0=DyC_txt.htm on Sept 11, 2011
[4.]
S.A. Fischer, R.K. Avery.
Screening of donor and recipient prior to solid organ transplantation.
Am J Transplant, 9 (2009), pp. S7-S18
[5.]
P.A. Grossi, J.A. Fishman.
Donor-derived infections in solid organ transplant recipients.
Am J Transplant, 9 (2009), pp. S19-S26
[6.]
F.L. Delmonico.
Cadaver donor screening for infectious agents in solid organ transplantation.
Clin Infect Dis, 31 (2000), pp. 781-786
[7.]
P. Martin-Davila, J. Fortun, R. Lopez-Velez, F. Norman, M. Montes de Oca, P. Zamarrón, et al.
Transmission of tropical and geographically restricted infections during solid-organ transplantation.
Clin Microbiol Rev, 21 (2008), pp. 60-96
[8.]
Directive 2010/45/EU of the European Parliament and of the Council of 7 July 2010 on standards of quality and safety of human organs intended for transplantation. Accessed at: http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=CELEX: 32010L0045(01):EN:HTML on September 11, 2011.
[9.]
M. Iwamoto, D.B. Jernigan, A. Guasch, M.J. Trepka, C.G. Blackmore, W.C. Hellinger, et al.
Transmission of West Nile virus from an organ donor to four transplant recipients.
N Engl J Med, 348 (2003), pp. 2196-2203
[10.]
L.A. Danziger-Isakov, S. Husain, M.L. Mooney, M.M. Hannan.
The novel 2009 H1N1 influenza virus pandemic: unique considerations for programs in cardiothoracic transplantation.
J Heart Lung Transplant, 28 (2009), pp. 1341-1347
[11.]
D. Kumar, R. Tellier, R. Draker, G. Levy, A. Humar.
Severe Acute Respiratory Syndrome (SARS) in a liver transplant recipient and guidelines for donor SARS screening.
Am J Transplant, 3 (2003), pp. 977-981
[12.]
R.J. Simonds, S.D. Holmberg, R.L. Hurwitz, T.R. Coleman, S. Bottenfield, L.J. Conley, et al.
Transmission of human immunodeficiency virus type 1 from a seronegative organ and tissue donor.
N Engl J Med, 326 (1992), pp. 726-732
[13.]
E. Muller, D. Kahn, M. Mendelson.
Renal transplantation between HIV-positive donors and recipients.
N Engl J Med, 362 (2010), pp. 2336-2337
[14.]
F. Yao, C. Seed, A. Farrugia, D. Morgan, S. Cordner, D. Wood, et al.
The risk of HIV, HBV, HCV and HTLV infection among musculoskeletal tissue donors in Australia.
Am J Transplant, 7 (2007), pp. 2723-2726
[15.]
J. Levitsky, K. Doucette.
Viral hepatitis in solid organ transplant recipients.
Am J Transplant, 9 (2009), pp. S116-S130
[16.]
R.T. Chung, S. Feng, F.L. Delmonico.
Approach to the managment of allograft recipients following the detection of hepatitis B virus in the prospective organ donor.
Am J Transplant, 1 (2001), pp. 185-191
[17.]
R.M. Madayag, L.B. Johnson, S.T. Bartlett, E.J. Schweitzer, N.T. Constantine, R.J. McCarter Jr., et al.
Use of renal allografts from donors positive for hepatitis B core antibody confers minimal risk for subsequent development of clinical hepatitis B virus disease.
Transplantation, 64 (1997), pp. 1781-1786
[18.]
B.J. Pereira, T.L. Wright, C.H. Schmid, A.S. Levey.
A controlled study of hepatitis C transmission by organ transplantation. The New England Organ Bank Hepatitis C Study Group.
Lancet, 345 (1995), pp. 484-487
[19.]
J.P. Ong, D.S. Barnes, Z.M. Younossi, T. Gramlich, B. Yen-Lieberman, M. Goormastic, et al.
Outcome of de novo hepatitis C virus infection in heart transplant recipients.
Hepatology, 30 (1999), pp. 1293-1298
[20.]
P.R. Pfau, R. Rho, D. DeNofrio, E. Loh, E.A. Blumberg, M.A. Acker, et al.
Hepatitis C transmission and infection by orthotopic heart transplantation.
J Heart Lung Transplant, 19 (2000), pp. 350-354
[21.]
B.R. Rosengard, S. Feng, E.J. Alfrey, J.G. Zaroff, J.C. Emond, M.L. Henry, et al.
Report of the Crystal City meeting to maximize the use of organs recovered from the cadaver donor.
Am J Transplant, 2 (2002), pp. 701-711
[22.]
B.D. Tugwell, P.R. Patel, I.T. Williams, K. Hedberg, F. Chai, O.V. Nainan, et al.
Transmission of hepatitis C to several organ and tissue recipients from an antibody-negative donor.
Ann Intern Med, 143 (2005), pp. 648-654
[23.]
J. Ahn, S.M. Cohen.
Transmission of human immunodeficiency virus and hepatitis C virus through liver transplantation.
Liver Transpl, 14 (2008), pp. 1603-1608
[24.]
J. Torre-Cisneros, M.A. Fariñas, J.J. Castón, J.M. Aguado, S. Cantisán, J. Carratalà, et al.
GESITRA-SEIMC/REIPI recommendations for the management of cytomegalovirus infection in solid-organ transplant patients.
Enferm Infecc Microbiol Clin, 29 (2011), pp. 735-758
[25.]
N.J. Cortes, B. Afzali, D. MacLean, D.J. Goldsmith, H. O'Sullivan, J. Bingham, et al.
Transmission of syphilis by solid organ transplantation.
Am J Transplant, 6 (2006), pp. 2497-2499
[26.]
A.L. Ridgeway, G.S. Warner, P. Phillips, M.S. Forshag, D.C. McGiffin, J.W. Harden, et al.
Transmission of Mycobacterium tuberculosis to recipients of single lung transplants from the same donor.
Am J Respir Crit Care Med, 153 (1996), pp. 1166-1168
[27.]
J. Torre-Cisneros, A. Doblas, J.M. Aguado, R. San Juan, M. Blanes, M. Montejo, et al.
Tuberculosis after solid-organ transplant: incidence, risk factors and clinical characteristics in the RESITRA (Spanish Network of Infection in Transplantation) cohort.
Clin Infect Dis, 48 (2009), pp. 1657-1665
[28.]
J.M. Aguado, J. Torre-Cisneros, J. Fortún, N. Benito, Y. Meije, A. Doblas, et al.
Tuberculosis in solid-organ transplant recipients: consensus statement of the group for the study of infection in transplant recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology.
Clin Infect Dis, 48 (2009), pp. 1276-1284
[29.]
R.B. Freeman, I. Giatras, M.E. Falagas, S. Supran, K. O’Connor, J. Bradley, et al.
Outcome of transplantation of organs procured from bacteremic donors.
Transplantation, 68 (1999), pp. 1107-1111
[30.]
O. Len, J. Gavaldá, M. Blanes, M. Montejo, R. San Juan, A. Moreno, et al.
Donor infection and transmission to the recipient of a solid allograft.
Am J Transplant, 8 (2008), pp. 2420-2425
[31.]
P. Coll, I. Montserrat, M. Ballester, F. March, C. Moya, D. Obrador, et al.
Epidemiologic evidence of transmission of donor-related bacterial infection through a transplanted heart.
J Heart Lung Transplant, 16 (1997), pp. 464-467
[32.]
R.D. Dowling, N. Baladi, M. Zenati, J.S. Dummer, R.L. Kormos, J.M. Armitage, et al.
Disruption of the aortic anastomosis after heart-lung transplantation.
Ann Thorac Surg, 49 (1990), pp. 118-122
[33.]
C. Lumbreras, F. Sanz, A. González, G. Pérez, M.J. Ramos, J.M. Aguado, et al.
Clinical significance of donor-unrecognized bacteremia in the outcome of solid-organ transplant recipients.
Clin Infect Dis, 33 (2001), pp. 722-726
[34.]
D. Van Raemdonck, A. Neyrinck, G.M. Verleden, L. Dupont, W. Coosemans, H. Decaluwé, et al.
Lung donor selection and management.
Proc Am Thorac Soc, 6 (2009), pp. 28-38
[35.]
I. Ruiz, J. Gavaldá, V. Monforte, O. Len, A. Román, C. Bravo, et al.
Donor-to-host transmission of bacterial and fungal infections in lung transplantation.
Am J Transplant, 6 (2006), pp. 178-182
[36.]
D. Hill, J.P. Dubey.
Toxoplasma gondii: transmission, diagnosis and prevention.
Clin Microbiol Infect, 8 (2002), pp. 634-640
[37.]
F. Derouin, H. Pelloux.
Prevention of toxoplasmosis in transplant patients.
Clin Microbiol Infect, 14 (2008), pp. 1089-1101
[38.]
A. Gallino, M. Maggiorini, W. Kiowski, X. Martin, W. Wunderli, J. Schneider, et al.
Toxoplasmosis in heart transplant recipients.
Eur J Clin Microbiol Infect Dis, 15 (1996), pp. 389-393
[39.]
C.N. Kotton, R. Lattes.
Parasitic infections in solid organ transplant recipients.
Am J Transplant, 9 (2009), pp. S234-S251
[40.]
Guidelines for preventing transmission of human immunodeficiency virus through transplantation of human tissue and organs. Centers for Disease Control and Prevention.
MMWR Recomm Rep, 43 (1994), pp. 1-17
[41.]
A. Humar, M. Morris, E. Blumberg, R. Freeman, J. Preiksaitis, B. Kiberd, et al.
Nucleic acid testing (NAT) of organ donors: is the ‘best’ test the right test? A consensus conference report.
Am J Transplant, 10 (2010), pp. 889-899
[42.]
A.L. Singer, L.M. Kucirka, R. Namuyinga, C. Hanrahan, A.K. Subramanian, D.L. Segev.
The high-risk donor: viral infections in solid organ transplantation.
Curr Opin Organ Transplant, 13 (2008), pp. 400-404
[43.]
A. Assal, V. Barlet, M. Deschaseaux, I. Dupont, P. Gallian, C. Guitton, et al.
Sensitivity of two hepatitis B virus, hepatitis C virus (HCV), and human immunodeficiency virus (HIV) nucleic acid test systems relative to hepatitis B surface antigen, anti-HCV, anti-HIV, and p24/anti-HIV combination assays in seroconversion panels.
Transfusion, 49 (2009), pp. 301-310
[44.]
A.P. Limaye, P.A. Connolly, M. Sagar, T.R. Fritsche, B.T. Cookson, L.J. Wheat, et al.
Transmission of Histoplasma capsulatum by organ transplantation.
N Engl J Med, 343 (2000), pp. 1163-1166
[45.]
M.B. Miller, R. Hendren, P.H. Gilligan.
Posttransplantation disseminated coccidioidomycosis acquired from donor lungs.
J Clin Microbiol, 42 (2004), pp. 2347-2349
[46.]
L. Fischer, M. Sterneck, M. Claus, A. Costard-Jäckle, B. Fleischer, H. Herbst, et al.
Transmission of Malaria tertiana by multi-organ donation.
Clin Transplant, 13 (1999), pp. 491-495
[47.]
Chagas disease after organ transplantation--Los Angeles. California, 2006.
MMWR Morb Mortal Wkly Rep, 55 (2006), pp. 798-800
[48.]
F. Salvador, O. Len, S. Molina, S. Sauleda, I. Bilbao, L. Castells, et al.
Safety of liver transplantation performed with Chagas seropositive donors to seronegative recipients.
Liver Transpl, 17 (2011), pp. 1304-1308
[49.]
M.J. Rodríguez-Hernández, M. Ruiz-Perez-Pipaon, E. Cañas, C. Bernal, F. Gavilán.
Strongyloides stercoralis hyperinfection transmitted by liver allograft in a transplant recipient.
Am J Transplant, 9 (2009), pp. 637-640
[50.]
B.D. Shames, A.M. D’Alessandro, H.W. Sollinger.
Human T-cell lymphotrophic virus infection in organ donors: a need to reassess policy?.
Am J Transplant, 2 (2002), pp. 658-663
[51.]
A. Srinivasan, E.C. Burton, M.J. Kuehnert, C. Rupprecht, W.L. Sutker, T.G. Ksiazek, et al.
Transmission of rabies virus from an organ donor to four transplant recipients.
N Engl J Med, 352 (2005), pp. 1103-1111
Copyright © 2012. Elsevier España S.L.. All rights reserved
